BioCardia, Inc. (BCDA) CEO Peter Altman on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/29/22
BioCardia to Host 2021 Financial Results and Corporate Update Conference Call on March 29, 2022GlobeNewsWire • 03/24/22
BioCardia Announces New Center for Medicare and Medicaid Services Reimbursement Code Applicable to the CardiAMP Cell Therapy ProcedureGlobeNewsWire • 03/22/22
BioCardia Receives No Objection Letter from Health Canada, Enabling Company to Expand CardiAMP Cell Therapy Heart Failure Trial into CanadaGlobeNewsWire • 03/01/22
Safety Board Recommends BioCardia's Heart Failure Cell Therapy To Continue UnchangedBenzinga • 02/14/22
BioCardia Announces Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as DesignedGlobeNewsWire • 02/14/22
BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart FailureBusiness Wire • 02/03/22
BioCardia Announces Participation at the Upcoming Digital Medicine & Medtech Showcase and the H.C. Wainwright BioConnect Virtual ConferenceGlobeNewsWire • 01/10/22
BioCardia Establishes New Manufacturing Facility to Enable Its Cell Therapy Product CandidatesGlobeNewsWire • 12/15/21
BioCardia Reports Third Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire • 11/10/21
Will BioCardia, Inc. (BCDA) Report Negative Q3 Earnings? What You Should KnowZacks Investment Research • 11/02/21
BioCardia Announces First Patient Treated in CardiAMP Cell Therapy Trial for Chronic Myocardial IschemiaGlobeNewsWire • 10/21/21
BioCardia Issued New U.S. Patent for Technology that Enhances Control for Interventional Catheter Based TherapiesGlobeNewsWire • 10/12/21
BioCardia Announces First Cross-Over Patient Treated in CardiAMP Cell Therapy Heart Failure TrialGlobeNewsWire • 10/07/21
BioCardia Announces Participation at the A.G.P. Biotech & Specialty Pharma Conference October 13, 2021 (Virtual Conference)GlobeNewsWire • 10/06/21
CardiAMP Cell Therapy Heart Failure Trial to be Featured in Two Presentations at Heart Failure Society of America Annual Meeting 2021GlobeNewsWire • 09/10/21
BioCardia Announces Participation at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021 (Virtual Conference)GlobeNewsWire • 09/09/21
BioCardia Reports Second Quarter 2021 Financial Results and Business HighlightsGlobeNewsWire • 08/12/21